Journals in Veterinary parasitology

1-10 of 11 results in All results

Anaerobe

• ISSN: 1075-9964
• 5 Year impact factor: 2.6
• Impact factor: 2.5

Anaerobe is essential reading for those who wish to remain at the forefront of discoveries relating to life processes of strictly anaerobes. The journal is multi-disciplinary, and provides a unique forum for those investigating strictly anaerobic organisms that cause infections in humans and animals, as well as anaerobes that play roles in microbiomes or environmental processes. Anaerobe will consider manuscripts on anaerobic bacteria, archaea, fungi, protists as well as bacteriophages of anaerobes.Relevant topics fall into the broad categories of:Anaerobes in human and animal diseasesAnaerobes in the microbiomeAnaerobes in the environmentAnaerobes in industrial processes (including biofuels and waste management)Microbial ecology of anaerobesClinical microbiology involving anaerobesPathogenesis of anaerobic organisms (including their toxins)Molecular biology and genetics of anaerobesTaxonomy of anaerobesPhysiology of anaerobesPapers describing innovative methodologies, technologies and applications to investigate anaerobic microorganisms are also of interest. Manuscripts describing novel species of obligate anaerobes will be reviewed, if the description of the new species also includes information showing novel phenotypic characteristics, pathogenicity and/or unique metabolic activity within the microbiome from which it was isolated. Manuscripts describing novel anaerobic species that are only different from other related members of a genus based on genotype will not be reviewed.Manuscript types accepted (see Guide for Authors for more information):Original research articles Original research reports on one or more of the above listed categories. Up to 4000 words, not including a structured abstract, figures, tables and references.Short Communications Presentation of brief observations that do not warrant a full-length publication. Up to 1500 words not including abstract, figures, tables and references. Short communications should report complete datasets and not preliminary findings.Reviews and minireviews Reviews are typically 7,000 words in length including relevant tables and/or figures. Mini-reviews are typically restricted to 2,500 words in length.*New from March 1st 2023: Anaerobe no longer accepts unsolicited reviews and standalone mini-reviews. Proposals for reviews and mini-reviews within the topics mentioned above are welcome for consideration by the journal. Please provide a proposed title and detailed outline of the topic to be covered to an editor-in-chief by email.Case reports Presentation of a short report on a significant clinical observation, preceded by a minireview (up to 2500 words) of the literature describing the background of similar cases/infections, what is known about the associated microbe, and other clinically relevant information. *New from March 2023: Case Reports will only be considered in this new format.Commentaries Occasionally, Anaerobe will consider publication of commentaries on important new work in the field. Such commentaries will be invited by the editors-in-chief. Suggestions for commentaries may be emailed to an Editor-in-Chief. Unsolicited commentaries will not be considered.Please note:1. Anaerobe does not accept manuscripts on descriptive, sequence-based surveys of microbiomes, even if the environments of the sampled ecosystems select for anaerobic species. However, when studies such as these are accompanied by direct, mechanistic assays of strictly anaerobic components, they will be considered for publication. 2. Anaerobe will not consider manuscripts that deal only with descriptive accounts of the beneficial effects of potentially novel probiotic strains, unless such strains belong to strictly anaerobic species that have previously not been associated with probiotic features. Anaerobe will continue to consider manuscripts for publication that address determinations of the specific mechanism(s) of action of anaerobic probiotic strains.

Subscribe

Experimental Parasitology

• ISSN: 0014-4894
• 5 Year impact factor: 1.6
• Impact factor: 1.4

Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe

International Journal for Parasitology

• ISSN: 0020-7519
• 5 Year impact factor: 3.5
• Impact factor: 3.7

Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology publishes the results of original research in all aspects of basic and applied parasitology, including all the fields covered by its Specialist Editors, and ranging from parasites and host-parasite relationships of intrinsic biological interest to those of social and economic importance in human and veterinary medicine and agriculture. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses.We do not publish new genome sequences and assemblies alone without new and significant insight into the biology of the parasite, the parasite-host relationship or mechanisms of pathogenesis. Because of its breadth of discipline coverage, the aims and significance of all contributions should be made clear to readers who are not expert in the particular subject of papers. In applied parasitology, it will tend to favour contributions of broader significance to the subject rather than narrow, highly specialised applications. The principal form of publication is the full length paper which contains substantial results from a major program of research. The Journal also provides a medium for the publication of shorter, but complete, papers reporting highly significant original findings, as Succinctus articles. It also publishes Thematic Issues incorporating papers on a topical theme and commissions papers with emphasis on shorter, focussed Reviews of topical issues and strategically important subjects. The Journal encourages critical comment and debate on matters of current controversy in parasitology via "Current Opinions".Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterThe International Journal for Parasitology has also launched two specialist, open access titles you are welcome to submit to:International Journal for Parasitology: Parasites and WildlifeInternational Journal for Parasitology: Drugs and Drug Resistance

Subscribe

International Journal for Parasitology: Drugs and Drug Resistance

• ISSN: 2211-3207
• 5 Year impact factor: 3.7
• Impact factor: 4.1

Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology – Drugs and Drug Resistance is one of a series of specialist, open access journals launched by the International Journal for Parasitology . It publishes the results of original research, as well as review articles, in the area of anti-parasite drug identification, development and evaluation, and parasite drug resistance. The journal also covers research into natural products as anti-parasitic agents, and bioactive parasite products. Studies can be aimed at unicellular or multicellular parasites of human or veterinary importance.A list showing the types of articles that are considered is included below. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses. Because of its breadth of organism coverage, all contributions should include relevant information about the parasite of interest in order to be comprehensible to non-experts in the particular subject of the articles. The principal forms of publication are full-length articles which contain substantial results from a major program of research, or reviews on topical issues and strategically important subjects. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication.In addition, the journal provides a medium for highlighting selected articles reporting highly significant original findings, as Editor's Choice Manuscripts. The journal encourages critical comment and debate on matters of current controversy in the area of parasite drug resistance and anti-parasite drugs via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).Types of articles considered:Compound library screening for inhibitors against enzymes or whole parasitesDrug target validation (chemical and/or genetic)Drug target identification (must include some inhibitor studies rather than characterisation of an enzyme, for example)Drug structure-activity relationship studiesMechanisms of drug action and resistanceReports of the development of drug resistance both in the field and laboratoryStudies on drug toxicity to the host (either on single host cells or whole organism)Reports on toxicity in the fieldComputational approaches to drug discovery or drug-target identificationDevelopment of assays directed at screening for inhibitorsDrug combination studiesNatural products as anti-parasitic agentsBioactive products produced by parasitesUse of live parasites as immunomodulatory agentsEpidemiological aspects of the emergence and spread of parasite drug resistanceHuman clinical trialsThe other specialist title in the series is International Journal for Parasitology: Parasites and Wildlife .

Subscribe

International Journal for Parasitology: Parasites and Wildlife

• ISSN: 2213-2244
• 5 Year impact factor: 2.1
• Impact factor: 2

Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology: Parasites and Wildlife (IJP-PAW) publishes the results of original research on parasites of all wildlife, invertebrate and vertebrate. This includes free-ranging,wild populations, semi-domesticated species (e.g. reindeer) and farmed populations of recently domesticated or wild-captured species (e.g. cultured fishes). Submissions describing studies on captive wildlife can be considered if they include relevant ecological, clinical, or epidemiological aspects. Articles on all aspects of wildlife parasitology are welcomed including taxonomy, evolutionary biology, biodiversity and distribution, ecology and epidemiology, population biology and host-parasite relationships. The impact of parasites on the health and conservation of wildlife is seen as an important area covered by the journal especially the potential role of environmental factors, for example, climate. Also important to the journal is One Health and the nature of interactions between wildlife, people and domestic animals, including disease emergence and zoonoses.The principal form of publication is the full-length article which contains substantial, original research. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication. In addition, the journal commissions articles with emphasis on shorter, focused reviews of topical and emerging issues as well as strategically important subjects. The journal encourages critical comment and debate on matters of current controversy in the area of parasites and wildlife via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).The other specialist title in the series is International Journal for Parasitology: Drugs and Drug Resistance .

Subscribe

Microbes and Infection

• ISSN: 1286-4579
• 5 Year impact factor: 3
• Impact factor: 2.6

A Journal on Infectious Agents and Host Defenses A publication of the Institut PasteurThis journal has no page charges, publication is free of charge.Microbes and Infection publishes 8 peer-reviewed issues per year in all fields of infection and immunity, covering the different levels of host-microbe interactions, and in particular:the molecular biology and cell biology of the crosstalk between hosts (human and model organisms) and microbes (viruses, bacteria, parasites and fungi), including molecular virulence and evasion mechanisms.the immune response to infection, including pathogenesis and host susceptibility.emerging human infectious diseases.systems immunology.molecular epidemiology/genetics of host pathogen interactions.microbiota and host "interactions".vaccine development, including novel strategies and adjuvants.Clinical studies, accounts of clinical trials and biomarker studies in infectious diseases, unless purely descriptive, are within the scope of the journal.Microbes and Infection publishes articles on human pathogens or pathogens of model systems. However, articles on other microbes can be published if they contribute to our understanding of basic mechanisms of host-pathogen interactions. Purely descriptive and preliminary studies are discouraged.Reviews of a major topic of current interest must be commissioned by a Microbes and Infection editor. Unsolicited contributions and presubmission enquiries will not be considered.Special issues focus on the present knowledge of a virulent microbe and the disease it causes, the immune response in infectious disease, or on critical issues relevant to the scope of the journal.The journal is entering its 20th year of publication, and Essential Science IndicatorsSM (ESI) states that "Microbes and Infection has had a significant impact in the field of Immunology." https://www.editorialmanager.com/MICINF/default.aspxhttps://www.pasteur.fr/fr/ceris/publications-scientifiques/microbes-infectionThe full-text articles, etc, are available at:https://www.sciencedirect.com/journal/microbes-and-infection

Subscribe

Molecular and Biochemical Parasitology

• ISSN: 0166-6851
• 5 Year impact factor: 1.6
• Impact factor: 1.4

Molecular and Biochemical Parasitology provides a medium for rapid publication of investigations of the molecular biology and biochemistry of parasitic protozoa and helminths and their molecular interactions with their definitive and intermediate hosts and their vectors.The main subject areas covered are:the structure, biosynthesis, degradation, properties and function of parasite biomolecules - DNA, RNA, proteins, lipids, carbohydrates and small molecular-weight substanceshost-parasite relationships particularly as related to specific parasite molecules and to the response of host cells to infectionvector-parasite relationships at the molecular levelintermediary metabolism and bioenergeticsdrug target characterization and the mode of action of antiparasitic drugsanalysis of gene function, expression, and of genome structure and stabilityanalysis of variation in parasite populations relevant to genetic exchange, pathogenesis, drug and vaccine target characterization, and drug resistance; please note that genetic variation data must be supported by phenotypic/experimental data showing the effect of the variation, and that papers reporting solely on allele frequencies in specific regions will not be accepted.parasite protein trafficking, organelle biogenesis, and cellular structure especially with reference to the roles of specific moleculesmolecular and biochemical aspects of membrane structure and functionparasite programmed cell death, development, and cell division at the molecular levelmethods reports - descriptions of novel or newly-optimized methods with broad applicability to molecular and biochemical parasitologyPapers will only be accepted for publication if they fall within these areas, if they contain original and complete work of high scientific quality, and if they are well presented. Papers solely confirming the conserved functions of genes previously studied in other organisms will not be considered. We welcome short communications documenting a succinct but clear and important advance.1. Original research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words per article (all text excluding tables and figure legends).2. Short Communications need not be formally structured as full papers but should describe significant new findings and observations. The manuscript should ideally contain no more than 4Figures/Tables and 3000 words. The abstract should be limited to 200 words.3. Methods Reports should contain descriptions of novel or newly-optimised methods with broad applicability to molecular parasitologists. The manuscript should ideally contain no more than 4 Figures/Tables and 3000 words. Results and Discussion are usually combined. The abstract should be limited to 200 words. Methods Reports must include a detailed step-by-step protocol and/or analysis code in the supplementary material.4. Review articles should cover subjects falling within the scope of the journal which are of active current interest. They may be submitted or invited by the Editors. Review articles should include insightful recommendations for future directions needed for achieving public health impacts. Review articles are limited to 15,000 words per article (all text excluding tables and figure legends). If you have a suggestion for a Review article topic please email Special Content Editor, Geoff Gobert: [email protected]. Perspective articles should include scientifically backed points of view regarding currently relevant, controversial or future-oriented topics pertinent to the scope of MBP. Note that only outlining recent advances in a given field is not acceptable for a Perspective article. Besides stimulating scientific discussion or future research, perspective articles should provide a novel conceptual framework for an old or timely issue. The authors should outline which research directions should be prioritized and highlight specific points explaining why they should be prioritized in future research. Perspective articles are limited to 6,000 words per article (all text excluding tables and figure legends).6. Letters to the Editor offering comment or useful critique on material published in the journal are welcome. Letters on "hot topics" are also welcome. Note that Letters to the Editors will also be externally reviewed but the decision to publish submitted letters rests with the Editors in Chief. A goal is to publish constructive letters that will permit an exchange of views which will be of benefit to both the journal and its readers. Letters to the Editor are limited to 2,000 words per article (all text excluding tables and figure legends).Most downloaded papersBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe

Parasitology International

• ISSN: 1383-5769
• 5 Year impact factor: 1.6
• Impact factor: 1.5

The Official, International Journal of the Japanese Society of ParasitologyParasitology International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe

Veterinary Immunology and Immunopathology

• ISSN: 0165-2427
• 5 Year impact factor: 1.7
• Impact factor: 1.4

An International Journal of Comparative ImmunologyThe journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.Ideas and suggestions for Special Issues are also welcome. These may focus on a planned conference/symposium for which a selection of the best papers could be published together (after peer review). Alternatively, they could consist of a group of invited papers which together present an up-to-date overview on an important immunological topic.

Subscribe

Veterinary Microbiology

• ISSN: 0378-1135
• 5 Year impact factor: 2.6
• Impact factor: 2.4

Veterinary Microbiology is concerned with bacterial and viral diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, but excluding fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials ('Scope or cope' and 'Scope or cope II') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, metagenomics data, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge related to microbial disease.Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.Papers will be rejected if standards of care of, or procedures performed on animals are not up to those expected of humane veterinary scientists. At a minimum, standards must meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland.

Subscribe